drugset / Trial / NCT01819779
Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)
RandomizedCrossoverOpen-labelBasic science
Summary
To assess the pharmacokinetic characteristics of valsartan and S-amlodipine after single oral administration of Exforge tab. 10/160mg, a combination formulation of valsartan and amlodipine as reference drug and Lodivixx tab
Timeline
- Start
- 2013-03
- Primary completion
- 2013-05
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | 10 mg | Oral |
| Subject | S-amlodipine | Unknown | 5 mg | — |
| Comparator | Valsartan | Small molecule | 160 mg | Oral |
Indications
No indication recorded.